-
Mashup Score: 1Jasmine Kamboj: POLICY webinar with the experts and leaders in advocacy and policy - OncoDaily - 4 day(s) ago
Jasmine Kamboj: POLICY webinar with the experts and leaders in advocacy and policy / cancer, fight against cancer, Global fight against cancer, Jasmine
Source: oncodaily.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Oncology Trialists and Their Minions - ILCN.org (ILCN/WCLC) - 2 month(s) ago
Poet and ILCN Editor-in-Chief Corey Langer, MD, illustrates the build-up and anticipation surrounding the release of research data.
Source: www.ilcn.orgCategories: General Medicine News, Oncologists1Tweet-
Oncology Trialists and Their Minions https://t.co/gHPesa3Gy9
-
-
Mashup Score: 15
About the survey This survey aims to evaluate oncologists’ attitudes, practices, and barriers to the use of liquid biopsy in clinical care. Your participation in this survey is voluntary. The survey will take 10-15 minutes to complete; answers are recorded anonymously. Data will be processed to identify global trends in liquid biopsy adoption, shed light on region-specific challenges, and assess liquid biopsy’s perceived value in the treatment of solid tumors. The findings will guide strategies to improve the implementation and effectiveness of liquid biopsy in cancer care worldwide. Please complete the survey below. Thank you! The International Society of Liquid Biopsy Committee
Source: docs.google.comCategories: General Medicine News, Oncologists1Tweet-
📢 @isliquidbiopsy conducting global survey 🌎 on #attitudes, #practices & #barriers of #liquidbiopsies for practicing #oncologists. Aim: Find #strategies to improve #implementation. Help shape this by completing survey here 👉: https://t.co/JfivOSne6h @A_OrtegaFranco… https://t.co/edpAGHlh0e https://t.co/wuEpMmhTJV
-
-
Mashup Score: 9Sarcoma Updates from ESMO 2024: Insights from Dr. Herbert Loong - 4 month(s) ago
Herbert Loong, Clinical Associate Professor in the Department of Clinical Oncology at the Chinese University of Hong Kong, discusses key sarcoma updates from…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
Sarcoma Updates from ESMO 2024: Insights from Dr. Herbert Loong https://t.co/wctKbe9Ygz via @YouTube
-
-
Mashup Score: 22025 Immunotherapy and Precision Oncology Forum (IPOF) - 4 month(s) ago
Submit an abstract and register to attend this exciting healthcare conference! April 5, 2025. Virtual and in-person options available.
Source: innovationsjournals.m-pages.comCategories: General Medicine News, Oncologists1Tweet-
RT @JIPOEditors: Registration is OPEN for the #Immunotherapy & #PrecisionOncology Forum - April 5, 2025 https://t.co/kzzs8iNkYr ❇️ In pers…
-
-
Mashup Score: 6Transforming the landscape of liver cancer detection and care - 5 month(s) ago
Nature Reviews Gastroenterology & Hepatology – In 2024, important studies highlighted the ongoing global battle against liver cancer, a deadly yet common cancer. Despite advances in treatments,…
Source: www.nature.comCategories: General Medicine News, Oncologists1Tweet-
RT @wonglaihung: What's new about #livercancer in 2024? @NatRevGastroHep #HCC https://t.co/Xiq00idK1I @TerryYip12 @CUHKMedicine @CUHKGI htt…
-
-
Mashup Score: 6Transforming the landscape of liver cancer detection and care - 5 month(s) ago
Nature Reviews Gastroenterology & Hepatology – In 2024, important studies highlighted the ongoing global battle against liver cancer, a deadly yet common cancer. Despite advances in treatments,…
Source: www.nature.comCategories: General Medicine News, Oncologists1Tweet-
RT @wonglaihung: What's new about #livercancer in 2024? @NatRevGastroHep #HCC https://t.co/Xiq00idK1I @TerryYip12 @CUHKMedicine @CUHKGI htt…
-
-
Mashup Score: 43NTRK gene fusion testing and management in lung cancer - 5 month(s) ago
In non-small cell lung cancer (NSCLC), oncogene dysregulation due to activating mutations, fusions or amplifications is a frequent event. These recurring oncogenic alterations enable cancer cell survival and growth [1,2]. Lung cancers harbouring oncogenic drivers tend to rely on aberrant signalling for survival and growth, a concept known as ‘oncogene addiction’ [2,3]. This dependency on oncogene signalling, however, generates a unique vulnerability that can be exploited with the use of selective targeted agents such as tyrosine kinase inhibitors (TKIs) [2,4].
Source: www.cancertreatmentreviews.comCategories: General Medicine News, Oncologists1Tweet-
Our recent review paper on #NTRK gene fusion testing in the management of #NSCLC. A truly international 🌎 effort to consolidate #bestpractice #recommendations for #testing and #treatment of #NTRKpositive disease. Full text available here: https://t.co/rOLQk1kevp @DrSanjayPopat… https://t.co/18B9Azm6xz https://t.co/jiVokjVfqW
-
-
Mashup Score: 4Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer - 6 month(s) ago
The role of a family history of lung cancer (LCFH) in screening using low-dose computed tomography (LDCT) has not been prospectively investigated with long-term follow-up.
Source: www.jto.orgCategories: General Medicine News, Oncologists1Tweet-
Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer - Journal of Thoracic Oncology https://t.co/SnxUCnOpAx
-
-
Mashup Score: 2Lung cancer screening in Asia Pacific: showcasing advances in implementation across the region - 6 month(s) ago
This webinar showcases the varying stages of screening implementation in the Asia-Pacific region, while highlighting common challenges and key lessons from r…
Source: www.youtube.comCategories: General Medicine News, Oncologists1Tweet-
Lung cancer screening in Asia Pacific: showcasing advances in implementa... https://t.co/oRqORWJnWP via @YouTube
-
RT @oncodaily: POLICY webinar with the experts and leaders in advocacy and policy - @JasmineKambojMD @ASCO https://t.co/H48VQQPvYm #ASCO…